Business Context and Reporting Period
Company: SANUWAVE Health, Inc. (SNWV)
Filing Type: Form 8-K (Current Report)
Report Date: March 26, 2026
Reporting Period: Fourth quarter and fiscal year ended December 31, 2025
The Company issued a press release on March 26, 2026, announcing financial results for the fourth quarter and full fiscal year 2025. A business update conference call was scheduled for March 27, 2026.
Key Financial Metrics
The provided filing text serves as a notification of the results announcement and does not contain specific numerical data. The following metrics are not disclosed in this document:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Note: Specific financial values are not present in the 8-K text; they are referenced as being contained in the attached press release (Exhibit 99.1) and the Company's investor website.
Material Changes
The filing text does not provide specific details regarding material changes in financial condition or operations compared to prior periods. It only confirms the issuance of results for the period ended December 31, 2025.
Guidance, Outlook, and Risks
Outlook and Commentary: Management indicated a business update via conference call on March 27, 2026. Further details on guidance or management commentary are not included in this filing text.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt.
Unusual Items: None disclosed in this text.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific revenue, profit, and cash flow figures for Q4 and FY 2025.
- Access the Company's investor website (www.sanuwave.com/investors) for the full presentation materials and conference call transcript.
- Verify the date and time of the conference call (March 27, 2026, 8:30 am EST) for management's outlook and Q&A.
- Confirm the trading symbol (SNWV) and exchange (Nasdaq) for current market data.